Use of macrolides in children: A review of the literature

Infections in Medicine

Volumn 19, Issue 6, 2002, Pages 279-285

  Cuzzolin, Laura ^a   Fanos, Vassilios ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Adverse drug events; Macrolides; Pediatrics

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; CEFACLOR; CEFTIBUTEN; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CISAPRIDE; CLARITHROMYCIN; CYCLOSPORIN; CYCLOSPORIN A; DICLOXACILLIN; DIGOXIN; DIRITHROMYCIN; DRUG METABOLITE; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; ERYTHROMYCIN ESTOLATE; ERYTHROMYCIN ETHYLSUCCINATE; MACROLIDE; METHYLPREDNISOLONE; PENICILLIN DERIVATIVE; PENICILLIN V; PENICILLIN V POTASSIUM; SULFONAMIDE; TETRACYCLINE; THEOPHYLLINE; TROLEANDOMYCIN; UNINDEXED DRUG; WARFARIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CHILD CARE; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; EXPERIENCE; FEMALE; FOOD DRUG INTERACTION; HUMAN; MALE; MEDICAL LITERATURE; PHARYNGITIS; PNEUMONIA; RESPIRATORY TRACT INFECTION; SIDE EFFECT; SKIN INFECTION; STREPTOCOCCUS;

EID: 0036087455     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Macrolide antibiotics in paediatric infectious diseases
2. Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states
3. Clarithromycin: A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients
4. Clarithromycin: A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential
5. Azithromycin: The first azalide antibiotic
6. The new macrolide antibiotics: Azithromycin and clarithromycin
7. Future indications for macrolides
8. Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin
9. The macrolides: Erythromycin, clarithromycin, and azithromycin
10. Epidemiology and mechanisms of resistance among respiratory tract pathogens
11. Erythromycin prophylaxis for recurrent otitis media
12. Decline of erythromycin resistance of group A streptococci in Japan
13. Resistance to erythromycin in group A streptococci
14. Clarithromycin: Where do we go from here?
15. Overview of the pharmacology of clarithromycin suspension in children and a comparison with that in adults
16. Clinical pharmacokinetics of antibacterial drugs in neonates
17. Pharmacokinetics of anti-infective agents in paediatric patients
18. Double blind and open label studies of azithromycin in the management of acute otitis media in children: A review
19. Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension
20. Pharmacokinetics of azithromycin in pediatric patients with acute otitis media
21. The pharmacokinetics of azithromycin in human serum and tissues
22. Bacteriological, pharmacokinetic and clinical evaluation of azithromycin in the pediatric field
23. Pharmacokinetic and clinical evaluation of azithromycin in the pediatric field
24. Pharmacokinetics of a clarithromycin suspension in infants and children
25. Laboratory and clinical studies on clarithromycin in the field of pediatrics
26. Basic and clinical studies on clarithromycin in pediatrics
27. Pharmacokinetic and clinical studies of clarithromycin in the pediatric field
28. History of macrolide use in pediatrics
29. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus
30. Infectious exanthems and unusual infections
31. Azithromycin for ocular toxoplasmosis
32. Azithromycin: A review of its use in paediatric infectious diseases
33. A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections
34. A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and / or soft tissue infections
35. Randomised controlled trial of single-dose azithromycin in treatment of trachoma
36. A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children
37. Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children
38. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients
39. Pharmacokinetic interactions of the macrolide antibiotics
40. Erythromycin-induced carbamazepine toxicity: A continuing problem
41. Adverse effects of macrolide antibacterials
42. Clarithromycin and pseudomembranous enterocolitis
43. Paediatric safety of azithromycin: Worldwide experience
44. Comparison of the tolerability of 3-day once-daily azithromycin suspension versus standard treatments for pediatric infectious diseases
45. Clinical tolerability and safety of azithromycin in children
46. Clinical safety and tolerance of azithromycin in children
47. Overview of the safety profile of clarithromycin suspension in paediatric patients
48. The Schonlein-Henoch syndrome: Glomerulonephritis following erythromycin
49. Acute interstitial nephritis due to drugs: Review of the literature with a report of nine cases
50. Interstitial nephritis with acute renal failure after erythromycin
51. Acute interstitial nephritis caused by erythromycin
52. Drug hypersensitivity causing granulomatous interstitial nephritis
53. Acute interstitial nephritis with septicemia and erythromycin
54. Azithromycin-induced acute interstitial nephritis
55. Safety profile of dirithromycin
56. Severe hepatorenal failure in a child receiving carbamazepine and erythromycin